CorMedix Inc. (CRMD) — Financial statements
Income statement, balance sheet, and cash flow for CorMedix Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 312↑617.0% | 43 | 0.00↓100.0% | 0.07↓65.7% | 0.19 | |
| Cost of Revenue | 36↑1027.1% | 3↑1452.1% | 0.21↑5405.1% | 0.00↓97.5% | 0.15 | |
| Gross Profit | 276↑584.6% | 40↑19695.9% | -0.21↓433.3% | 0.06↑46.8% | 0.04 | |
| Operating Expenses | ||||||
| R&D Expenses | 19↑390.4% | 4↓70.0% | 13↑23.2% | 11↓18.7% | 13 | |
| General & Administrative Expenses | 68↑127.7% | 30 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | -38↓232.4% | 29 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 30↓48.6% | 59↑64.9% | 36↑77.9% | 20↑22.4% | 16 | |
| Other Expenses | 76 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 126↑100.5% | 63↑28.5% | 49↑58.9% | 31↑4.1% | 29 | |
| Total Costs & Expenses | 162↑145.4% | 66↑34.5% | 49↑59.5% | 31↑3.6% | 30 | |
| Operating Results | ||||||
| Operating Income | 150↑771.6% | -22↑54.3% | -49↓59.9% | -31↓4.0% | -29 | |
| Depreciation & Amortization | 15↑4737.9% | 0.31↑337.8% | 0.07↓66.2% | 0.21↑18.1% | 0.18 | |
| EBITDA | 165↑970.1% | -19↑59.0% | -46↓53.8% | -30↓2.3% | -29 | |
| EBIT | 150↑878.4% | -19↑58.3% | -46↓53.0% | -30↓2.8% | -29 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↓58.1% | 3↓5.2% | 3↑795.4% | 0.30↑19548.1% | -0.00 | |
| Interest Income | 4↑49.1% | 3↓3.8% | 3↑722.6% | 0.33↑2163.5% | 0.01 | |
| Interest Expense | 3↑7541.8% | 0.04 | 0.00↓100.0% | 0.03↑66.3% | 0.02 | |
| Non-Operating Income | 0.00↑100.0% | -3↓15.6% | -3↓630.5% | -0.36↓5375.4% | 0.01 | |
| Other Income / Expenses | -0.13↓104.1% | 3↑15.8% | 3↑677.8% | 0.34↑1574.8% | -0.02 | |
| Income Before Tax | 150↑876.3% | -19↑58.3% | -46↓53.0% | -30↓2.8% | -29 | |
| Income Tax Expense | -13↓834.8% | -1 | 0.00↑100.0% | -0.59↑53.2% | -1 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 163↑1009.4% | -18↑61.3% | -46↓56.0% | -30↓5.3% | -28 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 163↑1009.4% | -18↑61.3% | -46↓56.0% | -30↓5.3% | -28 | |
| Bottom-Line Net Income | 163↑1009.4% | -18↑61.3% | -46↓56.0% | -30↓5.3% | -28 | |
| EPS (Basic) | 2.25↑850.0% | -0.30↑67.0% | -0.91↓23.0% | -0.74↑1.3% | -0.75 | |
| EPS (Diluted) | 2.04↑780.0% | -0.30↑67.0% | -0.91↓23.0% | -0.74↑1.3% | -0.75 | |
| Weighted Average Shares | 72↑22.4% | 59↑15.7% | 51↑26.8% | 40↑6.7% | 38 | |
| Weighted Average Diluted Shares | 80↑36.4% | 59↑15.7% | 51↑26.4% | 40↑6.9% | 38 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.